Mequitazine
Alternative Names: Butix; Histacoid; LM 209; Metaplexan; Mircol; Primalan; Quitadrill; Release; Sattol; VigiganLatest Information Update: 26 Aug 2004
Price :
$50 *
At a glance
- Originator Pierre Fabre; sanofi-aventis
- Developer Asahi Kasei; G.L. Pharma; Inava; Italfarmaco
- Class Antiallergics; Phenothiazines; Sedating antihistamines; Small molecules
- Mechanism of Action Histamine H1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Allergic conjunctivitis; Allergic rhinitis; Pruritus; Rhinitis; Urticaria
Most Recent Events
- 26 Aug 2004 Aventis has merged with Sanofi-Synthelabo to form Sanofi-Aventis
- 16 May 2001 Pierre Fabre has merged with bioMérieux Alliance
- 15 Jan 2001 Asahi Chemical is now called Asahi Kasei